TEDCO Announces Recent Investment in Aidar Health, Inc.
Maryland health technology company developing innovative medicine solutions to promote more personalized care
COLUMBIA, Md. (June 14, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a recent Seed Funds investment of $250,000 into Aidar Health, Inc., a health technology and digital medicine company. TEDCO’s Seed Funds invest in early-stage, technology and life sciences companies and provide access to gap financing.
“Our goal is to develop and deliver innovative digital medicine solutions to improve and empower personalized care,” said Sathya Elumalai, Aidar Health, Inc., president and CEO. “Through our products, we are able to offer access to high-quality care at home, helping to extend and improve the quality of life for many.”
The most recent round of seed funding came from its Life Sciences Investment Fund.
Aidar Health, Inc., based in Columbia, Md., is a company working to provide innovative healthcare technologies powered by data science to support patients and providers. Through their products, Aidar Health aims to enhance patients’ quality of life with chronic conditions while enabling positive health outcomes. One of these products, MouthLab, is a rapid health assessment device leveraging proprietary AI and machine learning algorithms. This allows for a more personalized healthcare experience for patients with chronic conditions.
“Aidar Health is working to improve care for patients with chronic conditions,” said Teddy Gresser, director of Seed Funds at TEDCO. “With the support of TEDCO’s investment, Aidar Health can continue innovating, thereby supporting and growing the life science and technology ecosystems in Maryland.”
TEDCO’s Seed Funds invest in companies showing promise of becoming venture-fundable companies or are likely to become sustainable through revenue, follow-on funding, or other forms of the corporate venture. For more information about TEDCO’s funding opportunities, visit https://www.tedcomd.com/funding.